Keywords: astrazeneca, begins, ph, iii, zactima, trial, anglo-swedish

AstraZeneca begins Ph III Zactima trial

Article | 05 March 2007

Print This

Anglo-Swedish drug major AstraZeneca says that it has initiated a Phase III study of its drug Zactima (vandetanib), in combination ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in